The effect of topical antihistamines used single dose daily in allergic conjunctivitis

Basit Öğe Kaydı
dc.authorid0000-0001-5902-8831en_US
dc.contributor.authorErdogan H.
dc.contributor.authorCam O.
dc.date.accessioned2024-07-12T21:52:37Z
dc.date.available2024-07-12T21:52:37Z
dc.date.issued2018en_US
dc.departmentMaltepe Üniversitesien_US
dc.description.abstractBackground and Objective: To evaluate the efficacy of 0.2% olopatadine and to compare olopatadine 0.1%, ketotifen 0.025% and emadastine 0.05% in the treatment of allergic conjunctivitis. Methods: In this retrospectively designed study, we investigated the files of patients who had been diagnosed with perineal or seasonal allergic conjunctivitis in the teaching hospital of Maltepe University between April 2017 and July 2017. We divided the patients into four groups. The patients in each group had similar symptoms and scores before medication. The first, second, third and fourth groups were prescribed olapatadine 0.1%, olopatadine 0.2%, ketotifen 0.025% and emedastine 0.05%, respectively. We evaluated the symptoms and signs of the patients on the 15th day after treatment, and compared the results between the groups. Results: We investigated the files of 80 patients. There were 20 patients in each group. We evaluated the symptoms and finding scores after treatment. The symptoms and findings of allergic conjunctivitis had improved in all the four groups. There was no difference in the treatment responses between the four groups. Conclusion: Olopatadine 0.2%, olopatadine 0.1%, ketotifen 0.025% and emedastine 0.05% were all equally effective in improving the signs and symptoms of allergic conjunctivitis. © 2018 Erdogan and Cam.en_US
dc.identifier.doi10.2174/1874364101812010330
dc.identifier.endpage337en_US
dc.identifier.issn1874-3641
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85062824307en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage330en_US
dc.identifier.urihttps://dx.doi.org/10.2174/1874364101812010330
dc.identifier.urihttps://hdl.handle.net/20.500.12415/8412
dc.identifier.volume12en_US
dc.identifier.wosWOS:000476644600015en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.publisherBentham Science Publishers B.V.en_US
dc.relation.ispartofOpen Ophthalmology Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKY03170
dc.subjectAllergic conjunctivitisen_US
dc.subjectAntihistaminesen_US
dc.subjectEmedastineen_US
dc.subjectKetotifenen_US
dc.subjectMast cell stabilizationen_US
dc.subjectOlopatadineen_US
dc.titleThe effect of topical antihistamines used single dose daily in allergic conjunctivitisen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu